Do pharmacokinetic polymorphisms explain treatment failure in high-risk patients with neuroblastoma?
about
Do pharmacokinetic polymorphisms explain treatment failure in high-risk patients with neuroblastoma?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Do pharmacokinetic polymorphis ...... k patients with neuroblastoma?
@en
Do pharmacokinetic polymorphis ...... k patients with neuroblastoma?
@nl
type
label
Do pharmacokinetic polymorphis ...... k patients with neuroblastoma?
@en
Do pharmacokinetic polymorphis ...... k patients with neuroblastoma?
@nl
prefLabel
Do pharmacokinetic polymorphis ...... k patients with neuroblastoma?
@en
Do pharmacokinetic polymorphis ...... k patients with neuroblastoma?
@nl
P2093
P2860
P1476
Do pharmacokinetic polymorphis ...... k patients with neuroblastoma?
@en
P2093
Bertil Kågedal
Francesco Bellanti
Oscar Della Pasqua
P2860
P2888
P304
P356
10.1007/S00228-010-0966-3
P478
67 Suppl 1
P577
2011-02-02T00:00:00Z
2011-05-01T00:00:00Z